Carly Forster


Analysts Provide Insight on Apple After New Details Emerge About the Apple Watch

At a press briefing in San Francisco on March 9th, Apple (NASDAQ: AAPL) gave details on its new Apple Watch including information on its …

Will McDonald’s New CEO Help Turn it Around? Analysts’ Weigh In

Fast-food giant McDonald’s (NYSE: MCD) has not seen as much success on Wall Street over the past 12 months as it has in the …

Canaccord Genuity Weighs in on 4 Bio-Resource Stocks

Crude oil was all anyone could talk about in the tail-end of 2014 and the beginning of 2015 as barrel prices dropped from …

Is Google Undervalued? Analysts Weigh In

Google’s (NASDAQ: GOOGL) stock has dropped about 5% over the last 12 months due to missing earnings expectations for the last eight out of …

Will Netflix’s Spending on New Original Content Help or Hurt?

Television and movie streaming website Netflix (NASDAQ: NFLX) has big plans for 2015. The company will be releasing its largest amount of original content …

Will Xiaomi’s New Action Camera Threaten GoPro? Analysts Weigh In

Shares of action camera company, GoPro (NASDAQ:GPRO), tumbled down 5% in trading on Monday, March 2nd after Chinese smartphone company, Xiaomi, launched a similar …

Looking Ahead of Wall Street: Salix Pharmaceuticals, Receptos, Tetraphase

A handful of bio-pharmaceutical stocks are announcing their financial results for the final quarter of 2014 this week. What should investors watch for?

Analysts Weigh in on Shake Shack in Reaction to High Valuation

Popular upscale hamburger chain Shake Shack (NYSE: SHAK) announced its highly coveted IPO on January 30th, pricing shares at $21 to start. Investors were …

Analysts Weigh in on Apple Amidst Apple Watch and Apple Car News

A lot of buzz has been circulating about Apple’s (NASDAQ:AAPL) newest product, the Apple Watch, poised to hit stores this coming April. In …

Cowen & Co Shares Positive Outlook On Celldex Therapeutics Following FDA ‘Breakthrough’ Approval

Shares of Celldex Therapeutics (NASDAQ: CLDX) shot up about 17.5% in trading on February 23rd following the company’s announcement that it was granted FDA approval …